Rosuvastatin (all strengths): Supply issue
Viatris, the supplier, advises that due to disruptions at the factory, there is limited supply of Viatris brand rosuvastatin tablets.
6 November 2026 | Rosuvastatin supply constrained
There is limited supply of most strengths of Rosuvastatin Mylan. Some 10 and 20 mg stock has been released to wholesalers on 6 November. Further stock will be released in due course.
Affected product
Due to disruptions at the factory, Rosuvastatin Viatris tablets are not available.
Schedule listings for rosuvastatin(external link)
People who take rosuvastatin
If you take rosuvastatin, you may be dispensed Rosuvastatin Mylan.
Same active ingredient, in the same amount
Please be assured, whether it's Viatris or Mylan, your medicine has the same amount of active ingredient and is designed to work in your body the same way.
We have funded the Mylan brand to ensure you can continue to access your treatment.
Medsafe approved
Medsafe, the government agency responsible for medicine safety, has reviewed the Mylan brand and approved it for sale in New Zealand. They have made sure they meet New Zealand standards of safety, quality, and effectiveness.
Widened access from 1 October 2026
If you have been paying for rosuvastatin, and still have repeats owing on your prescription, you will need a new prescription before you can access the funding for rosuvastatin. This is due to the way pharmacies are funded through Health NZ.
Alternative brand
The pack size for Rosuvastatin Mylan remains unchanged. The subsidy is the same as for Rosuvastatin Viatris.
Full details, including Pharmacodes, are listed in the Schedule.
Schedule listings for rosuvastatin(external link)
Medsafe approved
Rosuvastatin Mylan has received Medsafe approval for use in New Zealand, so it can be prescribed and dispensed as usual. The datasheet and CMI sheet are available on Medsafe's website.
Datasheet for Rosuvastatin Mylan [PDF, 134 MB](external link)
CMI for Rosuvastatin Mylan Film coated tablet [PDF, 341 MB](external link)
- Rosuvastatin supply issue | A5 Flyer [PDF 77 KB]
Rosuvastatin Viatris expected late 2026/early 2027
Viatris will continue to supply the Mylan brand until the Viatris brand is available again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)